Go Pro

MarketBeat Instant News Alerts

Brinker International logo with Consumer Discretionary background

Brinker International (NYSE:EAT) Upgraded at Northcoast Research

Northcoast Research raised shares of Brinker International from a "neutral" rating to a "buy" rating and set a $275.00 price objective on the stock in a research report on Tuesday.

NYSE:EAT
Read Brinker International (NYSE:EAT) Upgraded at Northcoast Research
Tiziana Life Sciences logo with Healthcare background

BTIG Research Reaffirms "Buy" Rating for Tiziana Life Sciences (NASDAQ:TLSA)

BTIG Research reiterated a "buy" rating on shares of Tiziana Life Sciences in a report on Tuesday.

NASDAQ:TLSA
Read BTIG Research Reaffirms "Buy" Rating for Tiziana Life Sciences (NASDAQ:TLSA)
Atlanticus logo with Finance background

Atlanticus (NASDAQ:ATLC) Earns "Buy" Rating from BTIG Research

BTIG Research reissued a "buy" rating and issued a $179.00 target price on shares of Atlanticus in a research report on Tuesday.

NASDAQ:ATLC
Read Atlanticus (NASDAQ:ATLC) Earns "Buy" Rating from BTIG Research
Upstart logo with Finance background

Upstart's (UPST) "Buy" Rating Reiterated at BTIG Research

BTIG Research reaffirmed a "buy" rating and set a $43.00 target price on shares of Upstart in a research note on Tuesday.

NASDAQ:UPST
Read Upstart's (UPST) "Buy" Rating Reiterated at BTIG Research
Adaptive Biotechnologies logo with Healthcare background

Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research

BTIG Research raised their target price on Adaptive Biotechnologies from $25.00 to $34.00 and gave the company a "buy" rating in a research note on Tuesday.

NASDAQ:ADPT
Read Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research
PTC Therapeutics logo with Healthcare background

Cantor Fitzgerald Boosts PTC Therapeutics (NASDAQ:PTCT) Price Target to $137.00

Cantor Fitzgerald lifted their price objective on shares of PTC Therapeutics from $130.00 to $137.00 and gave the company an "overweight" rating in a report on Tuesday.

NASDAQ:PTCT
Read Cantor Fitzgerald Boosts PTC Therapeutics (NASDAQ:PTCT) Price Target to $137.00

Trending News

All MarketBeat Instant News Alerts

McGraw Hill logo with Consumer Discretionary background

BTIG Research Reiterates "Buy" Rating for McGraw Hill (NYSE:MH)

NYSE:MH
Read BTIG Research Reiterates "Buy" Rating for McGraw Hill (NYSE:MH)
Hyperfine logo with Healthcare background

BTIG Research Reiterates Buy Rating for Hyperfine (NASDAQ:HYPR)

NASDAQ:HYPR
Read BTIG Research Reiterates Buy Rating for Hyperfine (NASDAQ:HYPR)
Tyra Biosciences logo with Healthcare background

Tyra Biosciences (NASDAQ:TYRA) Price Target Lowered to $29.00 at HC Wainwright

NASDAQ:TYRA
Read Tyra Biosciences (NASDAQ:TYRA) Price Target Lowered to $29.00 at HC Wainwright
Eldorado Gold logo with Materials background

Eldorado Gold (NYSE:EGO) Stock Rating Upgraded by Bank of America

NYSE:EGO
Read Eldorado Gold (NYSE:EGO) Stock Rating Upgraded by Bank of America
Travere Therapeutics logo with Healthcare background

Travere Therapeutics' (TVTX) Buy Rating Reaffirmed at HC Wainwright

NASDAQ:TVTX
Read Travere Therapeutics' (TVTX) Buy Rating Reaffirmed at HC Wainwright
Vista Gold logo with Materials background

Vista Gold (NYSEAMERICAN:VGZ) Given Buy Rating at HC Wainwright

NYSEAMERICAN:VGZ
Read Vista Gold (NYSEAMERICAN:VGZ) Given Buy Rating at HC Wainwright
Kymera Therapeutics logo with Healthcare background

Stifel Nicolaus Forecasts Strong Price Appreciation for Kymera Therapeutics (NASDAQ:KYMR) Stock

NASDAQ:KYMR
Read Stifel Nicolaus Forecasts Strong Price Appreciation for Kymera Therapeutics (NASDAQ:KYMR) Stock
Vicor logo with Industrials background

Vicor (NASDAQ:VICR) Receives Buy Rating from Needham & Company LLC

NASDAQ:VICR
Read Vicor (NASDAQ:VICR) Receives Buy Rating from Needham & Company LLC
RxSight logo with Healthcare background

Bank of America Has Lowered Expectations for RxSight (NASDAQ:RXST) Stock Price

NASDAQ:RXST
Read Bank of America Has Lowered Expectations for RxSight (NASDAQ:RXST) Stock Price
Warner Bros. Discovery logo with Communication Services background

Warner Bros. Discovery (NASDAQ:WBD) Price Target Raised to $31.00

NASDAQ:WBD
Read Warner Bros. Discovery (NASDAQ:WBD) Price Target Raised to $31.00
Real Brokerage logo with Real Estate background

Real Brokerage's (REAX) "Buy" Rating Reaffirmed at JonesTrading

NASDAQ:REAX
Read Real Brokerage's (REAX) "Buy" Rating Reaffirmed at JonesTrading
Sandisk logo with Technology background

Sandisk (NASDAQ:SNDK) Now Covered by Analysts at Rosenblatt Securities

NASDAQ:SNDK
Read Sandisk (NASDAQ:SNDK) Now Covered by Analysts at Rosenblatt Securities
Twilio logo with Technology background

Twilio (NYSE:TWLO) Price Target Raised to $290.00 at Rosenblatt Securities

NYSE:TWLO
Read Twilio (NYSE:TWLO) Price Target Raised to $290.00 at Rosenblatt Securities
Xometry logo with Industrials background

Xometry (NASDAQ:XMTR) Stock Price Expected to Rise, Rosenblatt Securities Analyst Says

NASDAQ:XMTR
Read Xometry (NASDAQ:XMTR) Stock Price Expected to Rise, Rosenblatt Securities Analyst Says
Williams Companies logo with Energy background

Melius Research Begins Coverage on Williams Companies (NYSE:WMB)

NYSE:WMB
Read Melius Research Begins Coverage on Williams Companies (NYSE:WMB)
Kinder Morgan logo with Energy background

Kinder Morgan (NYSE:KMI) Now Covered by Analysts at Melius Research

NYSE:KMI
Read Kinder Morgan (NYSE:KMI) Now Covered by Analysts at Melius Research
Enterprise Products Partners logo with Energy background

Enterprise Products Partners (NYSE:EPD) Coverage Initiated by Analysts at Melius Research

NYSE:EPD
Read Enterprise Products Partners (NYSE:EPD) Coverage Initiated by Analysts at Melius Research
Energy Transfer logo with Energy background

Energy Transfer (NYSE:ET) Earns Hold Rating from Analysts at Melius Research

NYSE:ET
Read Energy Transfer (NYSE:ET) Earns Hold Rating from Analysts at Melius Research
Pfizer logo with Healthcare background

Pfizer Refocuses Growth Strategy as New Products Offset COVID Decline

NYSE:PFE
Read Pfizer Refocuses Growth Strategy as New Products Offset COVID Decline
Thor Industries logo with Consumer Discretionary background

Thor Industries (NYSE:THO) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS

NYSE:THO
Read Thor Industries (NYSE:THO) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS
MillerKnoll logo with Industrials background

MillerKnoll (NASDAQ:MLKN) Updates Q2 2027 Earnings Guidance

NASDAQ:MLKN
Read MillerKnoll (NASDAQ:MLKN) Updates Q2 2027 Earnings Guidance
MillerKnoll logo with Industrials background

MillerKnoll (NASDAQ:MLKN) Updates FY 2027 Earnings Guidance

NASDAQ:MLKN
Read MillerKnoll (NASDAQ:MLKN) Updates FY 2027 Earnings Guidance
TeraWulf logo with Technology background

TeraWulf (NASDAQ:WULF) Rating Increased to Hold at Rothschild & Co Redburn

NASDAQ:WULF
Read TeraWulf (NASDAQ:WULF) Rating Increased to Hold at Rothschild & Co Redburn
Telix Pharmaceuticals logo with Healthcare background

Telix Pharmaceuticals (NASDAQ:TLX) Upgraded by Royal Bank Of Canada to "Moderate Buy" Rating

NASDAQ:TLX
Read Telix Pharmaceuticals (NASDAQ:TLX) Upgraded by Royal Bank Of Canada to "Moderate Buy" Rating

Featured Articles and Offers

Alert Categories

All Alerts